IL1B and rheumatoid arthritis: Various soluble mediators produced by these immune cells have been shown to correlate with disease progression and/or severity in RA, e.g., rheumatoid factor, anti-citrullinated peptide antibodies, tumor necrosis factor (TNF)α, interleukin (IL)-6, IL-1, and IL-17A (2, 4).